-
Recent Job Cuts in FDA and other pharmaceutical companies, and the impact on the industry
Muhammad Asim Niazi
May 15, 2025
The pharma industry faces downsizing in various areas, where a number of employees are fired or relieved of their duties.In addition to the manufacturing industry, the FDA also faces job and funding cuts.
-
Vical slashes staff after culling phase II antifungal
pharmaphorum
February 22, 2019
US biotech Vical is planning another round of job cuts after deciding to abandon its antifungal drug VL-2397, its last remaining clinical-stage asset.....
-
Eli Lilly plots 250 job cuts in €100M revamp of French plant
fiercepharma
January 13, 2019
Boehringer Ingelheim and Sanofi aren't the only pharma companies chopping jobs in France. Now, Eli Lilly says?it's cutting 250 positions as part of a "modernization" effort at a plant in Fegersheim.
-
Boehringer follows Sanofi with job cuts in France
pharmaphorum
December 12, 2018
Boehringer Ingelheim has confirmed it plans to axe more than 10% of its workforce in France, or more than 300 jobs, adding to several hundred losses at Sanofi last week.
-
Bayer to cut loose animal health, consumer brands and 12,000 jobs in huge shakeup
fiercepharma
December 04, 2018
At last, after back-and-forth speculation and denials, Bayer has revealed it will indeed cast off its animal health unit, a few consumer health brands and 12,000 jobs amid a large-scale restructuring that touches every area of its business.
-
Novo Nordisk expands job cuts to 1,300 as executives play down Lilly’s GLP-1 threat
fiercepharma
November 02, 2018
Diabetes giant Novo Nordisk has been slimming down this year, and now we know just how much. First it was 400 R&D jobs, then about 250 positions in the U.S., and now the company says it will have cut about 1,300 employees by the end of 2018.
-
Novo Nordisk to slash 250 U.S. jobs in the face of ongoing pricing pressure
fiercepharma
September 29, 2018
Days after swinging the ax on 400 R&D jobs in China and Denmark, diabetes giant Novo Nordisk is laying off again—this time in the U.S.
-
Gemphire cuts 33% of staff, including CFO, CMO
fiercebiotech
September 27, 2018
The FDA placed a partial clinical hold on gemcabene in 2004, requesting preclinical data to move forward with an end of phase 2 meeting in dyslipidemia indications.
-
Novartis, axing 19% of its workforce, faces big challenges with thinned ranks
fiercepharma
September 26, 2018
When Novartis created its business services unit in 2014, creating $3 billion in what the company called “productivity gains” as it reduced the costs associated with its back-office operations.
-
Akcea lays off 10% of staff following volanesorsen rejection
fiercebiotech
September 10, 2018
Akcea had built its headcount up to 270 in anticipation of bringing volanesorsen to market.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
